Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Q: What does CUSIP 92840H400 represent in this 13F holders report?

CUSIP 92840H400 is the security identifier for VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q3 2023?

34 institutional investors reported VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 92840H400

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 39,040,476
Total 13F shares: 3,003,814
Share change: +1,808,008
Total reported value: $15,739,243
Put/Call ratio: 27%
Price per share: $5.24
Number of holders: 34
Value change: +$10,117,983
Number of buys: 23
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 92840H400?
CUSIP 92840H400 identifies VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 92840H400:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Venrock Healthcare Capital Partners II, L.P.	3/4/5	10%+ Owner	— class O/S missing	20,637,286	$35,434,220	—	12 Jul 2022	3/4/5
VANGUARD GROUP INC	13F	Company	0.57%	223,911	$418,715	—	30 Jun 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.51%	198,816	$372,000	—	30 Jun 2023	13F
BlackRock Finance, Inc.	13F	Company	0.27%	105,006	$196,361	—	30 Jun 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.26%	101,070	$189,001	—	30 Jun 2023	13F
H. Ralph Snodgrass	3/4/5	PRES./CHIEF SCIENTIFIC OFFICER	— class O/S missing	98,859	$169,741	—	31 Dec 2021	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	57,322	$107,192	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.15%	57,316	$107,181	—	30 Jun 2023	13F
Y-Intercept (Hong Kong) Ltd	13F	Company	0.12%	47,696	$89,192	—	30 Jun 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.11%	41,363	$77,349	—	30 Jun 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	30,225	$56,520	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	0.07%	25,464	$47,618	—	30 Jun 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	19,871	$37,159	—	30 Jun 2023	13F
Mark Alan Smith	3/4/5	CHIEF MEDICAL OFFICER	— class O/S missing	19,915	$34,194	—	30 Jun 2022	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	12,302	$23,005	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	0.03%	10,353	$19,360	—	30 Jun 2023	13F
GPS Wealth Strategies Group, LLC	13F	Company	0.02%	8,441	$15,785	—	30 Jun 2023	13F
Middle East Fze Point72	13F	Individual	0.02%	7,720	$14,436	—	30 Jun 2023	13F
Performa Ltd (US), LLC	13F	Company	— class O/S missing	4,900	$9,163	—	30 Jun 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	4,393	$8,215	—	30 Jun 2023	13F
CWM, LLC	13F	Company	0.01%	3,782	$7,000	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	0.01%	3,420	$6,396	—	30 Jun 2023	13F
Jerrold Duane Dotson	3/4/5	VP, CFO	— class O/S missing	3,671	$6,303	—	30 Jun 2023	3/4/5
GROUP ONE TRADING LLC	13F	Company	0.01%	2,392	$4,473	—	30 Jun 2023	13F
FMR LLC	13F	Company	0%	1,936	$3,620	—	30 Jun 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1,145	$2,140	—	30 Jun 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	632	$1,182	—	30 Jun 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0%	946	$1,000	—	30 Jun 2023	13F
JPMORGAN CHASE & CO	13F	Company	0%	481	$899	—	30 Jun 2023	13F
Twin Lakes Capital Management, LLC	13F	Company	0%	416	$778	—	30 Jun 2023	13F
UBS Group AG	13F	Company	0%	117	$219	—	30 Jun 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0%	59	$110	—	30 Jun 2023	13F
CITIGROUP INC	13F	Company	0%	41	$76	—	30 Jun 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	40	$75	—	30 Jun 2023	13F
Russell Investments Group, Ltd.	13F	Company	0%	30	$56	—	30 Jun 2023	13F

Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) as of Q3 2023

As of 30 Sep 2023, Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,003,814 shares. The largest 10 holders included COMMODORE CAPITAL LP, VANGUARD GROUP INC, Ikarian Capital, LLC, Schonfeld Strategic Advisors LLC, BML Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., BlackRock Inc., BLAIR WILLIAM & CO/IL, GROUP ONE TRADING, L.P., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.